3626 results for «619»

Filter By

3626 results

Left main intervention in 2021

16 Dec 2021 – From GulfPCR-GIM 2021

In this session whose aim is to highlight imaging value, watch the case of a 64-year-old man with diabetes, hypertension and severe interstitial lung disease who presented with new onset of shortness of breath and functional class NYHA II-III for 3 days...

Left main intervention 2021

Complete revascularisation: from defining PCI strategy to PCI optimisation

22 Dec 2021 – From GulfPCR-GIM 2021

In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.

Complete revascularisation:

Mitral anatomy and imaging essentials

22 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, let's review the mitral anatomy from different standpoints before focusing on both mitral and transseptal punctures; then, let's try to transfer this knowledge into real practice by simulating some steps of these procedures.

Mitral anatomy and imaging essentials

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

M. Pighi

Author

Michele Pighi
Bioprosthetic valve fracture in ViV-TAVR

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure

03 Feb 2022

Didn’t find what you were looking for?